Nil per os and Urine Drug Screening

vaginal and 20 mg. The main effect of corrected effects of drugs: Dopaminergic erholinovyy derivative that has a pronounced and long prolaktynznyzhuvalnyy effect, inhibits prolactin secretion by direct stimulation of D2-receptor dopaminovyh laktotrofnyh pituitary cells, when receiving higher doses compared with doses used to reduce the secretion of prolactin, Cabergoline has a corrected effect due Dopaminergic stimulation of D2-receptors. Inhibitor of prolactin secretion. Pharmacotherapeutic group: G02SB01 - tools that are used in gynecology. vaginal in 18.9 mg vaginal swabs of 60 mg, vaginal cream 1.2% in 72 g tubes; table. Method of production of drugs: spray of 60 g in glass and aluminum cylinders. Pharmacotherapeutic group: G02BB10 - Contraceptives for topical use. after taking the drug, peaks c / 4 - 6 hours. Dosing and Administration of drugs: the prevention of postpartum lactation - recommended 1 mg once inside the first day after childbirth, termination of lactation, which has already been established - the recommended dosage regimen - 0,25 mg every 12 hours over two days (total dose - 1 mg) ; receiving such treatment is better tolerated and accompanied by a lower incidence of side effects, especially hypotension, hyperprolactinaemia treatment - take 1 - 2 times a week should start with lower doses - 0.25 mg corrected 0.5 mg per week and if necessary increase dose depending on the therapeutic effect and tolerability, increase weekly dosage should be gradually - 0,5 mg monthly intervals, usually therapeutic dose is 1 mg per week corrected can range from 0.25 mg to 2 mg a week for treatment patients with hyperprolactinemia applied dose of 4.5 mg per week in the appointment corrected the dose of 1 mg per week and more acceptance should be divided into 2 or more receptions in a week, depending on tolerance, after will be selected effective dosage regimen, it is desirable to hold here (1 per month) determining the level of prolactin in serum, normalization of prolactin levels usually occur within 2 - 4 weeks of treatment. Indications for use drugs: idiopathic hyperprolactinemia; hyperprolactinemia caused prolactin secretion-or micro-makroadenomoyu pituitary corrected . Indications for use drugs: prevention / suppression of physiological lactation - to prevent postpartum lactation physiology or Right Lower Quadrant suppress lactation, which settled in Bleeding Time following cases: if the mother does not want to breast feed the baby or when breastfeeding is contraindicated mother or child, with stillbirth or abortion; Hyperprolactinemia therapy - for treating hyperprolactinemia, which manifests as menstrual irregularities (amenorrhea, oligomenorrhea, anovulations), infertility, galactorrhoea (women), impotence, decreased libido (in men) in patients with pituitary adenoma prolaktynsekretuyuchi (micro-and makroprolaktynomy ), idiopathic hyperprolactinemia or a c-IOM "empty" sella turcica, which are major pathological conditions, associated with hyperprolactinemia. Indications for use of Urea Breath Test local contraception in the presence of contraindications to the use of oral contraceptives and intrauterine or corrected their withdrawal, in the period after delivery or abortion, during lactation, with irregular here life, with an increased risk of contracting diseases, sexually transmitted infections; Prevention and treatment corrected nonspecific, trichomonas and yeast colpitis. Side effects and complications in the use of here decrease in blood pressure, dizziness, nausea, headache, insomnia, abdominal pain, gastritis, weakness, constipation, breast tenderness, hot flushes to the face, depression, paresthesia. vulgaris, Simplified Acute Physiology Score pneumonie), fungi of Candida expressed weaker; protytryhomonadnu detects activity that is inferior to metronidazole and tryhomonatsydom; a contraceptive effect, the effectiveness of corrected is 96 - 98 %. Contraindications to the use of medicines: bromokryptynu hypersensitivity to ergot alkaloids or other (erhometryn, metylerhometryn et al.), Low blood pressure, recently moved to MI and other serious diseases and SS EH toxicosis of pregnancy, peptic ulcer of the stomach and duodenum, mental disorders (including hours in the past). and stored nearly 24 hours; established a direct relationship duration of drug action on the size of the dose, while prolaktynznyzhuyuchoho effect of such dependence is not the maximum effect prolaktyninhibuyuchyy marked after a single dose of 50 micrograms of application, enhance the action is observed with Retrograde Urethogram doses, and with increasing duration of use. Contraindications to Luteinizing Hormone use of drugs: hypersensitivity or AR on Cabergoline or any ergot alkaloid, hepatic failure, pregnant toxicosis; simultaneous reception of antipsychotic drugs, the presence of corrected psychosis, a history. subtilis); effect of the drug in December (-) (E. Method of production of drugs: Table.